GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » Cyclically Adjusted PB Ratio

Dae Hwa Pharm Co (XKRX:067080) Cyclically Adjusted PB Ratio : (As of Dec. 13, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Dae Hwa Pharm Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Dae Hwa Pharm Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dae Hwa Pharm Co Cyclically Adjusted PB Ratio Chart

Dae Hwa Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.29 3.88 2.21 2.10 2.03

Dae Hwa Pharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.15 2.03 2.22 - -

Competitive Comparison of Dae Hwa Pharm Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Dae Hwa Pharm Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dae Hwa Pharm Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dae Hwa Pharm Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Dae Hwa Pharm Co's Cyclically Adjusted PB Ratio falls into.



Dae Hwa Pharm Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Dae Hwa Pharm Co's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Dae Hwa Pharm Co's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book=Book Value per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=3978.129/*
=

Current CPI (Sep. 2024) = .

Dae Hwa Pharm Co Quarterly Data

Book Value per Share CPI Adj_Book
201412 3,284.792 99.098 0.000
201503 3,286.223 99.720 0.000
201506 3,336.995 100.050 0.000
201509 3,315.403 100.110 0.000
201512 3,457.806 100.220 0.000
201603 3,484.566 100.560 0.000
201606 3,524.871 100.790 0.000
201609 3,499.846 101.460 0.000
201612 3,746.400 101.560 0.000
201703 3,764.061 102.850 0.000
201706 3,819.178 102.610 0.000
201709 3,842.592 103.490 0.000
201712 4,340.280 102.990 0.000
201803 4,517.512 104.100 0.000
201806 4,339.580 104.130 0.000
201809 4,441.412 105.650 0.000
201812 4,347.408 104.350 0.000
201903 4,282.893 104.490 0.000
201906 4,506.767 104.880 0.000
201909 4,420.800 105.200 0.000
201912 4,622.711 105.120 0.000
202003 4,591.025 105.540 0.000
202006 4,531.284 104.870 0.000
202009 4,791.295 106.200 0.000
202012 4,692.733 105.765 0.000
202103 4,658.972 107.357 0.000
202106 4,817.065 107.579 0.000
202109 4,847.006 108.759 0.000
202112 4,548.497 109.676 0.000
202203 4,542.736 111.806 0.000
202206 4,467.261 114.083 0.000
202209 4,580.973 114.831 0.000
202212 4,452.495 115.200 0.000
202303 4,447.815 116.550 0.000
202306 4,411.220 117.140 0.000
202309 4,249.220 119.111 0.000
202312 4,180.708 118.848 0.000
202403 4,012.171 118.848 0.000
202406 4,003.551 0.000
202409 3,978.129 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dae Hwa Pharm Co  (XKRX:067080) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Dae Hwa Pharm Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Dae Hwa Pharm Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dae Hwa Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804
Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co Headlines

No Headlines